Chandra Ramanathan, Global Head of Pharma R&D Open Innovation, leads the Open Innovation Centers (OICs) around the world (US, Europe, Japan, China, and Singapore). The OICs focus on early access to breakthrough technologies, management of strategic alliances, and public-private partnerships.
Chandra’s previous roles at Bayer include Head of Open Innovation Center North America-East, Global Program Lead for External Innovation/Life Sciences, Global Launch Team Leader (copanlisib), and Head of Global Oncology Pipeline Marketing.
Prior to joining Bayer, Chandra worked at Wyeth (Pfizer) and Bristol-Myers Squibb in various roles in Drug Discovery, Applied Genomics, and Business Development & Licensing.
Chandra earned an MBA from the Columbia Business School, a PhD in Genomics/ Bioinformatics, an MS in Medicinal Chemistry, and a BS in Pharmacy.
Chandra is an adjunct assistant professor at the Tufts School of Medicine and is on the Board of Directors of MassBIO, the Massachusetts Biotech Council.